Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Lawrence Corey
Fred Hutchinson Cancer Research Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Immune Design Corporation
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Dr. Corey holds equity in Immune Design Corporation. He also has the right to receive licensing income from intellectual property licensed to Immune Design Corporation. Immune Design is involved in investigating immune responses and developing products to fight cancer, infection, allergy, and autoimmune disorders . Because this research project explores the immune response to HSV infection in certain populations, it is in line with Immune Design’s interests.
Cytotoxic T-Cell Responses to HSV in HIV-Infected Persons
This proposal aims to understand the mechanism by which host immune cells, specifically resident mucosal CD8+ T cells, contain herpes simplex virus-2 (HSV-2) reactivation at the source of their release from neuronal termini into basal keratinocytes of the genital skin/mucosa. Using laser capture microdissection and transcriptional arrays, we have shown that HSV-2 specific CD8+ T cells persist at the dermal-epidermal junction and that these cells express several cytolytic and antiviral cytokines. We now aim to further study the immune surveillance function of these cells and how they contain viral reactivation, a key concept that will lay the groundwork for better design and development of HSV-2 vaccines.
Filed on April 02, 2013.
Tell us what you know about Lawrence Corey's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Lawrence Corey filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Lawrence Corey | Fred Hutchinson Cancer Research Center | Conflict of Interest | Immune Design Corporation | >$600,000 |
| Lawrence Corey | Fred Hutchinson Cancer Research Center | Conflict of Interest | Immune Design Corporation | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.